Authors:
GALAJDA P
BALAZ D
MARTINKA E
MOKAN M
KUBISZ P
Citation: P. Galajda et al., INSULIN-TREATMENT INHIBITS PAI-1 PRODUCTION IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION, Clinical and applied thrombosis/hemostasis, 4(4), 1998, pp. 250-252
Authors:
GALAJDA P
MARTINKA E
STASKO J
MOKAN M
KUBISZ P
Citation: P. Galajda et al., PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAI-1) LEVELS ARE DECREASED IN NIDDM PATIENTS TREATED WITH INSULIN, Clinical and applied thrombosis/hemostasis, 4(2), 1998, pp. 138-139
Authors:
CORDONE L
GALAJDA P
VITRANO E
GASSMANN A
OSTERMANN A
PARAK F
Citation: L. Cordone et al., A REDUCTION OF PROTEIN-SPECIFIC MOTIONS IN CO-LIGATED MYOGLOBIN EMBEDDED IN A TREHALOSE GLASS, European biophysics journal, 27(2), 1998, pp. 173-176
Authors:
GALAJDA P
BALAZ D
MARTINKA E
SUTARIK C
KUBISZ P
MOKAN M
Citation: P. Galajda et al., PAI-1 LEVELS ARE DECREASED BY INSULIN-TREATMENT IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS WITH ENDOTHELIAL DYSFUNCTION, Diabetologia, 41, 1998, pp. 1273-1273
Authors:
GALAJDA P
BALAZ D
STASKO J
MOKAN M
KUBISZ P
Citation: P. Galajda et al., INSULIN-TREATMENT DECREASES PAI-1 LEVELS IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION, British Journal of Haematology, 102(1), 1998, pp. 133-133
Authors:
STASKO J
DROUET L
SORIA C
CAEN J
GALAJDA P
KUBISZ P
Citation: J. Stasko et al., EFFECTS OF ERYTHROPOIETIN, GM-CSF AND G-CSF ON PROLIFERATION AND RELEASE OF ENDOTHELIAL MARKERS IN HUVEC CULTURE, Thrombosis and haemostasis, 1997, pp. 452-452
Citation: M. Mokan et al., FIBRINOLYTIC PARAMETERS IN RELATION TO C-PEPTIDE AND ENDOGENOUS DIGITALIS-LIKE SUBSTANCES IN DIABETIC SUBJECTS, Diabetologia, 39, 1996, pp. 904-904
Authors:
MARTINKA E
MATUSEK J
OCHODNICKY M
KVETENSKY J
GALAJDA P
MOKAN M
Citation: E. Martinka et al., DIGOXIN-LIKE IMMUNOACTIVITY AND GLUCOSE-TOLERANCE IN PREGNANCY, Diabetes, nutrition & metabolism, 6(4), 1993, pp. 189-194